+1 347 708 0418
Influenza Medication market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Influenza Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Others
Segment by Application
Hospitals
Clinics
Pharmacies
Others
By Company
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International
Sun Pharmaceutical Industries
Mylan
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Influenza Medication Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.2.5 Amantadine
1.2.6 Rimantadine
1.2.7 Inosine
1.2.8 Others
1.3 Market by Application
1.3.1 Global Influenza Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Medication Sales Estimates and Forecasts 2017-2028
2.2 Global Influenza Medication Revenue Estimates and Forecasts 2017-2028
2.3 Global Influenza Medication Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Influenza Medication Sales by Region
2.4.1 Global Influenza Medication Sales by Region (2017-2022)
2.4.2 Global Sales Influenza Medication by Region (2023-2028)
2.5 Global Influenza Medication Revenue by Region
2.5.1 Global Influenza Medication Revenue by Region (2017-2022)
2.5.2 Global Influenza Medication Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Influenza Medication Sales by Manufacturers
3.1.1 Global Top Influenza Medication Manufacturers by Sales (2017-2022)
3.1.2 Global Influenza Medication Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza Medication in 2021
3.2 Global Influenza Medication Revenue by Manufacturers
3.2.1 Global Influenza Medication Revenue by Manufacturers (2017-2022)
3.2.2 Global Influenza Medication Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Medication Revenue in 2021
3.3 Global Influenza Medication Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Influenza Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Influenza Medication Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza Medication Sales by Type
4.1.1 Global Influenza Medication Historical Sales by Type (2017-2022)
4.1.2 Global Influenza Medication Forecasted Sales by Type (2023-2028)
4.1.3 Global Influenza Medication Sales Market Share by Type (2017-2028)
4.2 Global Influenza Medication Revenue by Type
4.2.1 Global Influenza Medication Historical Revenue by Type (2017-2022)
4.2.2 Global Influenza Medication Forecasted Revenue by Type (2023-2028)
4.2.3 Global Influenza Medication Revenue Market Share by Type (2017-2028)
4.3 Global Influenza Medication Price by Type
4.3.1 Global Influenza Medication Price by Type (2017-2022)
4.3.2 Global Influenza Medication Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Influenza Medication Sales by Application
5.1.1 Global Influenza Medication Historical Sales by Application (2017-2022)
5.1.2 Global Influenza Medication Forecasted Sales by Application (2023-2028)
5.1.3 Global Influenza Medication Sales Market Share by Application (2017-2028)
5.2 Global Influenza Medication Revenue by Application
5.2.1 Global Influenza Medication Historical Revenue by Application (2017-2022)
5.2.2 Global Influenza Medication Forecasted Revenue by Application (2023-2028)
5.2.3 Global Influenza Medication Revenue Market Share by Application (2017-2028)
5.3 Global Influenza Medication Price by Application
5.3.1 Global Influenza Medication Price by Application (2017-2022)
5.3.2 Global Influenza Medication Price Forecast by Application (2023-2028)
6 North America
6.1 North America Influenza Medication Market Size by Type
6.1.1 North America Influenza Medication Sales by Type (2017-2028)
6.1.2 North America Influenza Medication Revenue by Type (2017-2028)
6.2 North America Influenza Medication Market Size by Application
6.2.1 North America Influenza Medication Sales by Application (2017-2028)
6.2.2 North America Influenza Medication Revenue by Application (2017-2028)
6.3 North America Influenza Medication Market Size by Country
6.3.1 North America Influenza Medication Sales by Country (2017-2028)
6.3.2 North America Influenza Medication Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Influenza Medication Market Size by Type
7.1.1 Europe Influenza Medication Sales by Type (2017-2028)
7.1.2 Europe Influenza Medication Revenue by Type (2017-2028)
7.2 Europe Influenza Medication Market Size by Application
7.2.1 Europe Influenza Medication Sales by Application (2017-2028)
7.2.2 Europe Influenza Medication Revenue by Application (2017-2028)
7.3 Europe Influenza Medication Market Size by Country
7.3.1 Europe Influenza Medication Sales by Country (2017-2028)
7.3.2 Europe Influenza Medication Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Influenza Medication Market Size by Type
8.1.1 Asia Pacific Influenza Medication Sales by Type (2017-2028)
8.1.2 Asia Pacific Influenza Medication Revenue by Type (2017-2028)
8.2 Asia Pacific Influenza Medication Market Size by Application
8.2.1 Asia Pacific Influenza Medication Sales by Application (2017-2028)
8.2.2 Asia Pacific Influenza Medication Revenue by Application (2017-2028)
8.3 Asia Pacific Influenza Medication Market Size by Region
8.3.1 Asia Pacific Influenza Medication Sales by Region (2017-2028)
8.3.2 Asia Pacific Influenza Medication Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Influenza Medication Market Size by Type
9.1.1 Latin America Influenza Medication Sales by Type (2017-2028)
9.1.2 Latin America Influenza Medication Revenue by Type (2017-2028)
9.2 Latin America Influenza Medication Market Size by Application
9.2.1 Latin America Influenza Medication Sales by Application (2017-2028)
9.2.2 Latin America Influenza Medication Revenue by Application (2017-2028)
9.3 Latin America Influenza Medication Market Size by Country
9.3.1 Latin America Influenza Medication Sales by Country (2017-2028)
9.3.2 Latin America Influenza Medication Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Influenza Medication Market Size by Type
10.1.1 Middle East and Africa Influenza Medication Sales by Type (2017-2028)
10.1.2 Middle East and Africa Influenza Medication Revenue by Type (2017-2028)
10.2 Middle East and Africa Influenza Medication Market Size by Application
10.2.1 Middle East and Africa Influenza Medication Sales by Application (2017-2028)
10.2.2 Middle East and Africa Influenza Medication Revenue by Application (2017-2028)
10.3 Middle East and Africa Influenza Medication Market Size by Country
10.3.1 Middle East and Africa Influenza Medication Sales by Country (2017-2028)
10.3.2 Middle East and Africa Influenza Medication Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Corporation Information
11.1.2 Daiichi Sankyo Company Overview
11.1.3 Daiichi Sankyo Company Influenza Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Daiichi Sankyo Company Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Daiichi Sankyo Company Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Influenza Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Natco Pharma
11.3.1 Natco Pharma Corporation Information
11.3.2 Natco Pharma Overview
11.3.3 Natco Pharma Influenza Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Natco Pharma Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Natco Pharma Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Overview
11.4.3 F. Hoffmann-La Roche Influenza Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 F. Hoffmann-La Roche Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 F. Hoffmann-La Roche Recent Developments
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Corporation Information
11.5.2 Teva Pharmaceutical Overview
11.5.3 Teva Pharmaceutical Influenza Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Teva Pharmaceutical Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Pharmaceutical Recent Developments
11.6 Sandoz International
11.6.1 Sandoz International Corporation Information
11.6.2 Sandoz International Overview
11.6.3 Sandoz International Influenza Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sandoz International Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sandoz International Recent Developments
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Corporation Information
11.7.2 Sun Pharmaceutical Industries Overview
11.7.3 Sun Pharmaceutical Industries Influenza Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sun Pharmaceutical Industries Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharmaceutical Industries Recent Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Overview
11.8.3 Mylan Influenza Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mylan Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Influenza Medication Industry Chain Analysis
12.2 Influenza Medication Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Medication Production Mode & Process
12.4 Influenza Medication Sales and Marketing
12.4.1 Influenza Medication Sales Channels
12.4.2 Influenza Medication Distributors
12.5 Influenza Medication Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Influenza Medication Industry Trends
13.2 Influenza Medication Market Drivers
13.3 Influenza Medication Market Challenges
13.4 Influenza Medication Market Restraints
14 Key Findings in The Global Influenza Medication Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Influenza Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Zanamivir
Table 3. Major Manufacturers of Oseltamivir
Table 4. Major Manufacturers of Peramivir
Table 5. Major Manufacturers of Amantadine
Table 6. Major Manufacturers of Rimantadine
Table 7. Major Manufacturers of Inosine
Table 8. Major Manufacturers of Others
Table 9. Global Influenza Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Influenza Medication Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Influenza Medication Sales by Region (2017-2022) & (K Units)
Table 12. Global Influenza Medication Sales Market Share by Region (2017-2022)
Table 13. Global Influenza Medication Sales by Region (2023-2028) & (K Units)
Table 14. Global Influenza Medication Sales Market Share by Region (2023-2028)
Table 15. Global Influenza Medication Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Influenza Medication Revenue Market Share by Region (2017-2022)
Table 17. Global Influenza Medication Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Influenza Medication Revenue Market Share by Region (2023-2028)
Table 19. Global Influenza Medication Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Influenza Medication Sales Share by Manufacturers (2017-2022)
Table 21. Global Influenza Medication Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Influenza Medication Revenue Share by Manufacturers (2017-2022)
Table 23. Influenza Medication Price by Manufacturers (2017-2022) &(USD/Unit)
Table 24. Global Influenza Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Influenza Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Medication as of 2021)
Table 26. Influenza Medication Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Influenza Medication Product Offered
Table 28. Date of Manufacturers Enter into Influenza Medication Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 31. Global Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 32. Global Influenza Medication Sales Share by Type (2017-2022)
Table 33. Global Influenza Medication Sales Share by Type (2023-2028)
Table 34. Global Influenza Medication Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Influenza Medication Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Influenza Medication Revenue Share by Type (2017-2022)
Table 37. Global Influenza Medication Revenue Share by Type (2023-2028)
Table 38. Influenza Medication Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Influenza Medication Price Forecast by Type (2023-2028) & (USD/Unit)
Table 40. Global Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 41. Global Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 42. Global Influenza Medication Sales Share by Application (2017-2022)
Table 43. Global Influenza Medication Sales Share by Application (2023-2028)
Table 44. Global Influenza Medication Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Influenza Medication Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Influenza Medication Revenue Share by Application (2017-2022)
Table 47. Global Influenza Medication Revenue Share by Application (2023-2028)
Table 48. Influenza Medication Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Influenza Medication Price Forecast by Application (2023-2028) & (USD/Unit)
Table 50. North America Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 51. North America Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 52. North America Influenza Medication Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Influenza Medication Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 55. North America Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 56. North America Influenza Medication Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Influenza Medication Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Influenza Medication Sales by Country (2017-2022) & (K Units)
Table 59. North America Influenza Medication Sales by Country (2023-2028) & (K Units)
Table 60. North America Influenza Medication Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Influenza Medication Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 63. Europe Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 64. Europe Influenza Medication Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Influenza Medication Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 67. Europe Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 68. Europe Influenza Medication Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Influenza Medication Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Influenza Medication Sales by Country (2017-2022) & (K Units)
Table 71. Europe Influenza Medication Sales by Country (2023-2028) & (K Units)
Table 72. Europe Influenza Medication Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Influenza Medication Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 75. Asia Pacific Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 76. Asia Pacific Influenza Medication Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Influenza Medication Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 79. Asia Pacific Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 80. Asia Pacific Influenza Medication Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Influenza Medication Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Influenza Medication Sales by Region (2017-2022) & (K Units)
Table 83. Asia Pacific Influenza Medication Sales by Region (2023-2028) & (K Units)
Table 84. Asia Pacific Influenza Medication Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Influenza Medication Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 87. Latin America Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 88. Latin America Influenza Medication Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Influenza Medication Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 91. Latin America Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 92. Latin America Influenza Medication Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Influenza Medication Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Influenza Medication Sales by Country (2017-2022) & (K Units)
Table 95. Latin America Influenza Medication Sales by Country (2023-2028) & (K Units)
Table 96. Latin America Influenza Medication Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Influenza Medication Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 99. Middle East and Africa Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 100. Middle East and Africa Influenza Medication Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Influenza Medication Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 103. Middle East and Africa Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 104. Middle East and Africa Influenza Medication Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Influenza Medication Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Influenza Medication Sales by Country (2017-2022) & (K Units)
Table 107. Middle East and Africa Influenza Medication Sales by Country (2023-2028) & (K Units)
Table 108. Middle East and Africa Influenza Medication Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Influenza Medication Revenue by Country (2023-2028) & (US$ Million)
Table 110. Daiichi Sankyo Company Corporation Information
Table 111. Daiichi Sankyo Company Description and Major Businesses
Table 112. Daiichi Sankyo Company Influenza Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Daiichi Sankyo Company Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Daiichi Sankyo Company Recent Developments
Table 115. GlaxoSmithKline Corporation Information
Table 116. GlaxoSmithKline Description and Major Businesses
Table 117. GlaxoSmithKline Influenza Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. GlaxoSmithKline Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. GlaxoSmithKline Recent Developments
Table 120. Natco Pharma Corporation Information
Table 121. Natco Pharma Description and Major Businesses
Table 122. Natco Pharma Influenza Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Natco Pharma Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Natco Pharma Recent Developments
Table 125. F. Hoffmann-La Roche Corporation Information
Table 126. F. Hoffmann-La Roche Description and Major Businesses
Table 127. F. Hoffmann-La Roche Influenza Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. F. Hoffmann-La Roche Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. F. Hoffmann-La Roche Recent Developments
Table 130. Teva Pharmaceutical Corporation Information
Table 131. Teva Pharmaceutical Description and Major Businesses
Table 132. Teva Pharmaceutical Influenza Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Teva Pharmaceutical Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Teva Pharmaceutical Recent Developments
Table 135. Sandoz International Corporation Information
Table 136. Sandoz International Description and Major Businesses
Table 137. Sandoz International Influenza Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Sandoz International Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Sandoz International Recent Developments
Table 140. Sun Pharmaceutical Industries Corporation Information
Table 141. Sun Pharmaceutical Industries Description and Major Businesses
Table 142. Sun Pharmaceutical Industries Influenza Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Sun Pharmaceutical Industries Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Sun Pharmaceutical Industries Recent Developments
Table 145. Mylan Corporation Information
Table 146. Mylan Description and Major Businesses
Table 147. Mylan Influenza Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Mylan Influenza Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Mylan Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Influenza Medication Distributors List
Table 153. Influenza Medication Customers List
Table 154. Influenza Medication Market Trends
Table 155. Influenza Medication Market Drivers
Table 156. Influenza Medication Market Challenges
Table 157. Influenza Medication Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Medication Product Picture
Figure 3. Global Influenza Medication Market Share by Type in 2021 & 2028
Figure 3. Zanamivir Product Picture
Figure 4. Oseltamivir Product Picture
Figure 5. Peramivir Product Picture
Figure 6. Amantadine Product Picture
Figure 7. Rimantadine Product Picture
Figure 8. Inosine Product Picture
Figure 9. Others Product Picture
Figure 10. Global Influenza Medication Market Share by Application in 2021 & 2028
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Pharmacies
Figure 14. Others
Figure 15. Influenza Medication Report Years Considered
Figure 16. Global Influenza Medication Sales 2017-2028 (K Units)
Figure 17. Global Influenza Medication Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Influenza Medication Revenue 2017-2028 (US$ Million)
Figure 19. Global Influenza Medication Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Influenza Medication Sales Market Share by Region (2017-2022)
Figure 21. Global Influenza Medication Sales Market Share by Region (2023-2028)
Figure 22. North America Influenza Medication Sales YoY (2017-2028) & (K Units)
Figure 23. North America Influenza Medication Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Influenza Medication Sales YoY (2017-2028) & (K Units)
Figure 25. Europe Influenza Medication Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Influenza Medication Sales YoY (2017-2028) & (K Units)
Figure 27. Asia-Pacific Influenza Medication Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Influenza Medication Sales YoY (2017-2028) & (K Units)
Figure 29. Latin America Influenza Medication Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Influenza Medication Sales YoY (2017-2028) & (K Units)
Figure 31. Middle East & Africa Influenza Medication Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Influenza Medication Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Influenza Medication in the World: Market Share by Influenza Medication Revenue in 2021
Figure 34. Global Influenza Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Influenza Medication Sales Market Share by Type (2017-2028)
Figure 36. Global Influenza Medication Revenue Market Share by Type (2017-2028)
Figure 37. Global Influenza Medication Sales Market Share by Application (2017-2028)
Figure 38. Global Influenza Medication Revenue Market Share by Application (2017-2028)
Figure 39. North America Influenza Medication Sales Market Share by Type (2017-2028)
Figure 40. North America Influenza Medication Revenue Market Share by Type (2017-2028)
Figure 41. North America Influenza Medication Sales Market Share by Application (2017-2028)
Figure 42. North America Influenza Medication Revenue Market Share by Application (2017-2028)
Figure 43. North America Influenza Medication Sales Share by Country (2017-2028)
Figure 44. North America Influenza Medication Revenue Share by Country (2017-2028)
Figure 45. U.S. Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Influenza Medication Sales Market Share by Type (2017-2028)
Figure 48. Europe Influenza Medication Revenue Market Share by Type (2017-2028)
Figure 49. Europe Influenza Medication Sales Market Share by Application (2017-2028)
Figure 50. Europe Influenza Medication Revenue Market Share by Application (2017-2028)
Figure 51. Europe Influenza Medication Sales Share by Country (2017-2028)
Figure 52. Europe Influenza Medication Revenue Share by Country (2017-2028)
Figure 53. Germany Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 54. France Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Influenza Medication Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Influenza Medication Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Influenza Medication Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Influenza Medication Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Influenza Medication Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Influenza Medication Revenue Share by Region (2017-2028)
Figure 64. China Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 67. India Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 69. Taiwan Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 73. Philippines Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Influenza Medication Sales Market Share by Type (2017-2028)
Figure 75. Latin America Influenza Medication Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Influenza Medication Sales Market Share by Application (2017-2028)
Figure 77. Latin America Influenza Medication Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Influenza Medication Sales Share by Country (2017-2028)
Figure 79. Latin America Influenza Medication Revenue Share by Country (2017-2028)
Figure 80. Mexico Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Influenza Medication Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Influenza Medication Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Influenza Medication Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Influenza Medication Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Influenza Medication Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Influenza Medication Revenue Share by Country (2017-2028)
Figure 89. Turkey Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 91. U.A.E Influenza Medication Revenue (2017-2028) & (US$ Million)
Figure 92. Influenza Medication Value Chain
Figure 93. Influenza Medication Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Buy
